Skip to main content
Menu
  • Meet IdyllaTM
    • IdyllaTM Platform
    • Oncology Tests
    • Publications
  • Oncology
    • Oncology Tests
    • Oncologist
    • Pathologist
  • Oncology Research
    • Research Assays
    • IIS Information
    • On-Demand Webinars
  • Partnering
  • Press & Events
    • Press Releases
    • Events
  • About Us
    • Team
    • Our Distributors
    • Careers
    • Download Center
    • Contact
  • IFU(link is external)
  • Secure area
  • Global
  • United States
Open/Close
  • Search
  • Contact us
  • 1-844-443-9552
  • Subscribe to news
  • Global
  • United States

Multicenter NSCLC comparison study using IdyllaTM GeneFusion

  1. Home
  2. Publications
  3. Multicenter NSCLC comparison study using IdyllaTM GeneFusion
Menu
  • Meet IdyllaTM
    • IdyllaTM Platform
    • Oncology Tests
    • Publications
  • Oncology
    • Oncology Tests
    • Oncologist
    • Pathologist
  • Oncology Research
    • Research Assays
    • IIS Information
    • On-Demand Webinars
  • Partnering
  • Press & Events
    • Press Releases
    • Events
  • About Us
    • Team
    • Our Distributors
    • Careers
    • Download Center
    • Contact
Back to overview

Visit our global website for more information

Publications
  • Meet IdyllaTM
  • Oncology
  • Oncology Research
  • Partnering
  • Press & Events
  • About Us

Biocartis US Inc.

2 Pierce Place, Suite 1510

Itasca, IL 60143

Phone: +1 (844) 443-9552

customerserviceUS@bio­cartis.com(link sends email)

 

Biocartis Global

  • Subscribe to news
  • Contact us
  • Request demo
  • Download center
  • LinkedIn
  • Facebook
  • YouTube
  • Twitter
  • Purchase conditions
  • Cookie policy
  • Privacy policy
  • Terms of use
© 2025 Biocartis Created by O2 Agency(link is external)

Disclaimer

This information concerns a use that has not been approved or cleared by the Food and Drug Administration.

The opinions and conclusions expressed in the following publications are those of the individual authors and do not necessarily reflect the views and opinions of Biocartis and/or its employees.